Search
Now showing items 1-2 of 2
Patient Registries in Idiopathic Pulmonary Fibrosis
(American Journal of Respiratory and Critical Care Medicine, 2019-07-15)
Over the past decade, several large registries of patients with idiopathic pulmonary fibrosis (IPF) have been established. These registries are collecting a wealth of longitudinal data on thousands of patients with this ...
Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation
(Annals of the American Thoracic Society, 2019-07)
To the Editor:
Idiopathic pulmonary fibrosis (IPF) is a debilitating, progressive, fatal, fibrosing lung disease (1, 2). Pirfenidone and nintedanib are oral antifibrotics with demonstrated efficacy in reducing lung ...